Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Obstructive Lung Diseases

  Free Subscription


Articles published in Rev Mal Respir

Retrieve available abstracts of 46 articles:
HTML format
Text format



Single Articles


    March 2018
  1. DEVILLIER P, Ghasarossian C, Terrioux P, Schiratti M, et al
    [Persistent asthma: Chronic therapy quantitative compliance in daily practice].
    Rev Mal Respir. 2018 Mar 30. pii: S0761-8425(18)30037.
    PubMed     Text format     Abstract available


  2. DECCACHE A, Didier A, Mayran P, Jeziorski A, et al
    [Asthma: Adapting the therapeutic follow-up according to the medical and psychosocial profiles].
    Rev Mal Respir. 2018 Mar 27. pii: S0761-8425(17)30937.
    PubMed     Text format     Abstract available


  3. RIVIERE S, Delmas MC, Iwatsubo Y
    [Asthma and socioeconomic characteristics in France in 2012].
    Rev Mal Respir. 2018 Mar 27. pii: S0761-8425(18)30028.
    PubMed     Text format     Abstract available


    February 2018
  4. BARNIG C, Martin C
    [Asthma and the microbiome].
    Rev Mal Respir. 2018 Feb 23. pii: S0761-8425(17)31022.
    PubMed     Text format     Abstract available


  5. BENZAQUEN J, Pradelli J, Padovani B, Marquette CH, et al
    [Emphysema, did you say emphysema?]
    Rev Mal Respir. 2018 Feb 2. pii: S0761-8425(17)30275.
    PubMed     Text format     Abstract available


    January 2018
  6. BRAUN JJ, Delmas C, Charloux A, Schultz P, et al
    [Vocal cord dyskinesia and/or asthma].
    Rev Mal Respir. 2018 Jan 31. pii: S0761-8425(17)30936.
    PubMed     Text format     Abstract available


    September 2017
  7. BEYDON N, Delclaux C
    [Digital action plan for asthma exacerbations (PANAME)].
    Rev Mal Respir. 2017 Sep 15. pii: S0761-8425(17)30224.
    PubMed     Text format     Abstract available


    June 2017
  8. ROCCHI S, Reboux G
    [European birth cohorts: Early life exposure to microorganisms and health impact].
    Rev Mal Respir. 2017;34:635-644.
    PubMed     Text format     Abstract available


  9. PADOIN C
    [Role of therapeutic drug monitoring in pulmonary infections].
    Rev Mal Respir. 2017;34:693-705.
    PubMed     Text format     Abstract available


  10. SOUMAGNE T, Caillaud D, Degano B, Dalphin JC, et al
    [Differences and similarities between occupational and tobacco induced COPD].
    Rev Mal Respir. 2017;34:607-617.
    PubMed     Text format     Abstract available


    May 2017
  11. JEBRAK G, Burgel PR, Caillaud D, Deslee G, et al
    [Changing patterns of medication prescription for COPD patients in France. Impact of long-acting muscarinic antagonists' availability].
    Rev Mal Respir. 2017;34:535-543.
    PubMed     Text format     Abstract available


    April 2017
  12. JOUNEAU S, Dres M, Guerder A, Bele N, et al
    Management of acute exacerbations of chronic obstructive pulmonary disease (COPD). Guidelines from the Societe de pneumologie de langue francaise (summary).
    Rev Mal Respir. 2017;34:282-322.
    PubMed     Text format     Abstract available


    March 2017
  13. LAFOREST L, Belhassen M, Devouassoux G, Didier A, et al
    [Therapeutic adherence in asthma in France: A general review].
    Rev Mal Respir. 2017 Mar 27. pii: S0761-8425(17)30039.
    PubMed     Text format     Abstract available


  14. ROCHE N, Ajjouri R, Compagnon A, Van Der Molen T, et al
    [French data from the Continuing to Confront COPD (C2C) survey].
    Rev Mal Respir. 2017;34:180-187.
    PubMed     Text format     Abstract available


    February 2017
  15. PEROTIN JM, Barnig C
    [Omalizumab: Beyond anti-IgE properties].
    Rev Mal Respir. 2017;34:121-133.
    PubMed     Text format     Abstract available


    January 2017
  16. FUHRMAN C, Moutengou E, Roche N, Delmas MC, et al
    Prognostic factors after hospitalization for COPD exacerbation.
    Rev Mal Respir. 2017;34:1-18.
    PubMed     Text format     Abstract available


  17. POURCHEZ J, Leclerc L, Sarry G, Vergnon JM, et al
    [Bench-test evaluation of spacer devices for fluticasone delivery to infants].
    Rev Mal Respir. 2017;34:29-35.
    PubMed     Text format     Abstract available


    December 2016
  18. DELMAS MC, Guignon N, Leynaert B, Moisy M, et al
    [Increase in asthma prevalence among young children in France].
    Rev Mal Respir. 2016 Dec 2. pii: S0761-8425(16)30199.
    PubMed     Text format     Abstract available


  19. ZYSMAN M, Chabot F, Devillier P, Housset B, et al
    Pharmacological treatment optimization for stable chronic obstructive pulmonary disease. Proposals from the Societe de Pneumologie de Langue Francaise.
    Rev Mal Respir. 2016;33:911-936.
    PubMed     Text format     Abstract available


  20. RABEC C, Cuvelier A, Cheval C, Jaffre S, et al
    [Noninvasive ventilation. The 2015 guidelines from the Groupe Assistance Ventilatoire (GAV) of the Societe de Pneumologie de Langue Francaise (SPLF)].
    Rev Mal Respir. 2016;33:905-910.
    PubMed     Text format     Abstract available


  21. CHINET T, Dumoulin J, Honore I, Braun JM, et al
    [The place of inhaled corticosteroids in COPD].
    Rev Mal Respir. 2016;33:877-891.
    PubMed     Text format     Abstract available


    October 2016
  22. DEGANO B, Guillien A, Soumagne T
    [What place should we give to symptoms in the diagnosis of COPD?]
    Rev Mal Respir. 2016;33:648-651.
    PubMed     Text format    


  23. PLANTIER L, Pradel A, Delclaux C
    [Mechanisms of non-specific airway hyperresponsiveness: Methacholine-induced alterations in airway architecture].
    Rev Mal Respir. 2016;33:735-743.
    PubMed     Text format     Abstract available


  24. PETITPIERRE N, Beigelman C, Letovanec I, Lazor R, et al
    [Cryptogenic organizing pneumonia].
    Rev Mal Respir. 2016;33:703-717.
    PubMed     Text format     Abstract available


  25. KHAYATH N, Qi S, de Blay F
    [Chronic obstructive pulmonary disease (COPD) and the interior environment].
    Rev Mal Respir. 2016;33:666-674.
    PubMed     Text format     Abstract available


    September 2016
  26. MENOU A, Pain M, Pivette J, Chenivesse C, et al
    [Importance of comorbidities in the anemia of COPD: Economic implications and 3-year survival analysis].
    Rev Mal Respir. 2016;33:565-72.
    PubMed     Text format     Abstract available


    July 2016
  27. BOCQUILLON V, Briault A, Reymond E, Arbib F, et al
    [Prediction of the efficiency of endoscopic lung volume reduction by valves in severe emphysema].
    Rev Mal Respir. 2016 Jul 18. pii: S0761-8425(16)30128.
    PubMed     Text format     Abstract available


  28. DE WOLF J, Bonnette P, Sage E, Hamid A, et al
    [What place for lung volume reduction surgery for emphysema?]
    Rev Mal Respir. 2016 Jul 18. pii: S0761-8425(16)30099.
    PubMed     Text format     Abstract available


    June 2016
  29. GRAVIER FE, Bonnevie T, Medrinal C, Debeaumont D, et al
    [Noninvasive ventilation during pulmonary rehabilitation in COPD patients].
    Rev Mal Respir. 2016;33:422-30.
    PubMed     Text format     Abstract available


    May 2016
  30. RAHERISON C, Mayran P, Jeziorski A, Deccache A, et al
    [Patients with asthma: Disease control, patients' perceptions and observance. Results of the French REALISE survey].
    Rev Mal Respir. 2016 May 2. pii: S0761-8425(16)30040.
    PubMed     Text format     Abstract available


  31. BEAURIVAGE D, Boulay ME, Frenette E, Boulet LP, et al
    [Development and validation of patient's knowledge measurement tools: The model of the Questionnaire de Connaissances sur l'Asthme destine aux Patients Adultes (QCA-PA)].
    Rev Mal Respir. 2016;33:350-64.
    PubMed     Text format     Abstract available


  32. GAIES E, Jebabli N, Lakhal M, Klouz A, et al
    [Delayed convulsion after lidocaine instillation for bronchoscopy].
    Rev Mal Respir. 2016;33:388-90.
    PubMed     Text format     Abstract available


  33. M'SAAD S, Kammoun K, Yangui I, Fourati H, et al
    [Combined pulmonary fibrosis and emphysema associated with microscopic polyangiitis].
    Rev Mal Respir. 2016;33:391-6.
    PubMed     Text format     Abstract available


  34. ROMAND P, Kelkel E, Saint-Raymond C, Glas N, et al
    [Severe uncontrolled asthma in patients over 75 years old: Treatment with omalizumab].
    Rev Mal Respir. 2016;33:397-400.
    PubMed     Text format     Abstract available


    April 2016
  35. DIDIER A, Chabot F
    [Updated guidelines for management and monitoring of asthmatic patients: The Societe de pneumologie de langue francaise maintains the control].
    Rev Mal Respir. 2016;33:269-70.
    PubMed     Text format    


    March 2016
  36. DALPHIN JC
    [COPD: Gender equality now!].
    Rev Mal Respir. 2016;33:203-5.
    PubMed     Text format    


  37. CROIZET A, Perriot J, Merson F, Aublet-Cuvelier B, et al
    [Smoking cessation in older smokers. A retrospective study in 181 older smokers managed in a smoking cessation clinic].
    Rev Mal Respir. 2016;33:241-7.
    PubMed     Text format     Abstract available


  38. BODLET A, Mouthuy J, Pilette C
    [Bacterial endotoxin as a trigger for eosinophilic asthma].
    Rev Mal Respir. 2016;33:261-3.
    PubMed     Text format     Abstract available


    February 2016
  39. BURGEL PR, Bergeron A, Knoop C, Dusser D, et al
    [Small airway diseases and immune deficiency].
    Rev Mal Respir. 2016;33:145-55.
    PubMed     Text format     Abstract available


  40. PRADERE P, Garcia G, Humbert M, Aubier M, et al
    [Omalizumab: What have we learned after ten years of prescription?].
    Rev Mal Respir. 2016;33:117-27.
    PubMed     Text format     Abstract available


  41. ANDUJAR P, Dalphin JC
    [Occupational chronic obstructive pulmonary diseases. Legal aspects and practical management].
    Rev Mal Respir. 2016;33:91-101.
    PubMed     Text format     Abstract available


    January 2016
  42. BOURBEAU J
    [The benefits of prospective cohorts in COPD].
    Rev Mal Respir. 2016;33:1-4.
    PubMed     Text format    


  43. SOYEZ F, Ninot G, Herkert A, Phin Huyn S, et al
    [Validation of an evaluation questionnaire for COPD acute exacerbations (Exascore)].
    Rev Mal Respir. 2016;33:17-24.
    PubMed     Text format     Abstract available


  44. PALOT A, Charpin D
    [The feasibility of screening for COPD and asthma in the general population].
    Rev Mal Respir. 2016;33:25-31.
    PubMed     Text format     Abstract available


  45. KELKEL E, Herengt F, Ben Saidane H, Veale D, et al
    [COLIBRI: Improving clinical practice and producing relevant scientific data].
    Rev Mal Respir. 2016;33:5-16.
    PubMed     Text format     Abstract available


  46. DENDEN S, Bouden B, Boudawara Keskes N, Knani J, et al
    [COPD characteristics in subjects carrying the rare alpha-1 antitrypsin variant PIMMmalton].
    Rev Mal Respir. 2016;33:32-40.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: